Title of article
Efficacy and tolerability of MK-0974 (telcagepant), a new oral antagonist of calcitonin gene-related peptide receptor, compared with zolmitriptan for acute migraine: a randomised, placebo-controlled, parallel-treatment trial
Author/Authors
Tony W. Ho، نويسنده , , Michel D Ferrari، نويسنده , , David W Dodick، نويسنده , , Vince Galet، نويسنده , , James Kost، نويسنده , , Xiaoyin Fan، نويسنده , , Heather Leibensperger، نويسنده , , Samar Froman، نويسنده , , Christopher Assaid، نويسنده , , Christopher Lines، نويسنده , , Hille Koppen، نويسنده , , Paul K Winner، نويسنده ,
Issue Information
روزنامه با شماره پیاپی سال 2008
Pages
9
From page
2115
To page
2123
Abstract
Summary
Background
Calcitonin gene-related peptide (CGRP) probably has a role in migraine pathophysiology, and antagonism of its receptors might provide treatment without the vasoconstrictor effects of triptans. We aimed to assess the clinical profile of
Journal title
The Lancet
Serial Year
2008
Journal title
The Lancet
Record number
593858
Link To Document